A Phase II Trial Assessing the Accuracy of Tumor Bed Biopsies in Predicting Pathologic Response in Patients With Clinical/Radiologic Complete Response After Neoadjuvant Chemotherapy in Order to Explore the Feasibility of Breast Conserving Treatment

Investigator: Tejal Patel, MD

Study Coordinator: Minh Truong

Status: Enrolling

ClinicalTrials.gov Number: NCT03188393

Phone: 346.238.6403

Protocol Number: Pro00017822


This phase II trial studies how well biopsy of breast after chemotherapy works in predicting pathologic response in patients with stage II-IIIA breast cancer undergoing breast conserving surgery. Tumor tissue collected from biopsy before surgery may help to check if chemotherapy destroyed the breast cancer cells and may be compared to the tumor removed during surgery to check if they are the same.
More to Explore
Live Chat Available